Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies

Abstract excerpt

Bispecific antibodies represent a significant advancement in therapeutic antibody engineering, offering the ability to simultaneously target two distinct antigens. This dual-targeting capability enhances therapeutic efficacy, especially in complex diseases, such as cancer and autoimmune disorders, where drug resistance and incomplete target coverage are prevalent challenges. Bispecific antibodies facilitate...

Topics

Join the communities discussing this publication.

• Monoclonal and Polyclonal Antibodies Research
• Protein purification and stability
• Toxin Mechanisms and Immunotoxins